Related Experiment Video
Updated: Aug 14, 2026
08:34
Isolation of Atrial Myocytes from Adult Mice
Published on: July 25, 2019
ProBNP-derived peptides in cardiac disease
1Department of Clinical Biochemistry, Rigshospitalet, University of Copenhagen Denmark. JPG@dadlnet.dk
Summary
Cardiac natriuretic peptides, like atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP), are key heart disease markers. Measuring these peptides shows promise for diagnosing and managing ischemic heart disease.
Area of Science:
- Cardiology
- Endocrinology
- Molecular Biology
Background:
- Natriuretic peptides regulate fluid balance, vascular tone, and growth.
- Cardiac natriuretic peptides (ANP and BNP) are established diagnostic, therapeutic, and prognostic markers in cardiology.
- C-type natriuretic peptide (CNP) is a local vascular peptide, not primarily cardiac.
Observation:
- The failing heart synthesizes and secretes ANP and BNP.
- Increased plasma concentrations of proBNP-derived peptides correlate with cardiac conditions, particularly ventricular dysfunction.
- Myocardial hypoxia elevates local BNP gene expression, linking it to ischemic heart disease.
Findings:
- Established clinical applications exist for measuring plasma proBNP-derived peptides.
- Evidence highlights increased cardiac BNP expression in ischemic heart disease.
- Plasma proBNP peptide measurement may offer new avenues for coronary artery disease screening.
Implications:
- ProBNP-derived peptides are valuable biomarkers for cardiac conditions.
- Further research into BNP expression in ischemic heart disease is warranted.
- Plasma BNP measurements could enhance early detection and management of coronary artery disease.
Related Concept Videos
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...